2019 annual financial data

Corbus Pharmaceuticals Holdings 2019 Net margin

Direct answer

Net margin was -197.69%.

Operating income was -77.1M USD and net income was -71.45M USD.
Operating cash flow was -45.72M USD.

Get free Corbus Pharmaceuticals Holdings email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
36.14M USD
Operating income
-77.1M USD
Net income
-71.45M USD
Operating cash flow
-45.72M USD